Association between contrast media volume-glomerular filtration rate ratio and contrast-induced acute kidney injury after primary percutaneous coronary intervention

Angiology

Volumn 66, Issue 6, 2015, Pages 519-524

  Celik, Omer ^a   Ozturk, Derya ^a   Akin, Fatih ^b   Ayca, Burak ^c   Yalcln, Ahmet Arif ^a   Erturk, Mehmet ^a   Blylk, Ismail ^a   Ayaz, Ahmet ^a   Akturk, Ibrahim Faruk ^a   Enhos, Aslm ^a   Aslan, Serkan ^a  

^a Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Education and Research Hospital   (Turkey)

^b MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^c Education and Research Hospital   (Turkey)

Author keywords

contrast media volume estimated glomerular filtration ratio; contrast induced acute kidney injury; primary percutaneous coronary intervention

Indexed keywords

CONTRAST MEDIUM; CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTRAST INDUCED NEPHROPATHY; CONTRAST MEDIA VOLUME; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VOLUME; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; DIAGNOSTIC USE; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UPREGULATION;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 84931088452     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714542277     Document Type: Article

References (31)

1. Donald SB, Daniel IS Grossman's Cardiac Catheterization, Angiography, and Intervention. 7 th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007:36-75. Donald SB, ed. Philadelphia, PA: Lippincott Williams and Wilkins ; 2007: 36-75.
2. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005 ; 21 ((2)). 261-280
3. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006 ; 98 (6A). 5K - 13K
4. Meschi M, Detrenis S, Musini S, Strada E, Savazzi G. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy. Crit Care Med. 2006 ; 34 ((8)). 2060-2068
5. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short and long-term clinical outcomes in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2010 ; 3 ((5)). 491-498
6. Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006 ; 98 (6A). 14K - 20K
7. Naruse H, Ishii J, Hashimoto T, et al. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing emergency coronary intervention. Circ J. 2012 ; 76 (8). 1848-1855
8. Abe D, Sato A, Hoshi T, et al. Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention - results from the Ibaraki cardiovascular assessment study registry. Circ J. 2013 ; 78 ((1)). 85-91
9. Mager A, VakninAssa H, Lev EI, Bental T, Assali A, Kornowski R. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv. 2011 ; 78 ((2)). 198-201
10. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 ; 76 ((1)). 142-154
11. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989 ; 2 ((5)). 358-367
12. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006 ; 145 ((4)). 247-254
13. Fliser D, Laville M, Covic A, et al. A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012 ; 27 ((12)). 4263-4272
14. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 ; 44 ((7)). 1393-1399
15. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008 ; 71 ((1)). 62-72
16. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005 ; 95 ((1)). 13-19
17. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002 ; 105 ((19)). 2259-2264
18. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Wiviott SD. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation. 2012 ; 125 ((3)). 497-504
19. Wi J, Ko YG, Kim JS, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011 ; 97 ((21)). 1753-1757
20. Raposeiras-Roubín S, Aguiar-Souto P, Barreiro-Pardal C, et al. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. Angiology. 2013 ; 64 ((1)). 31-39
21. Golshahi J, Nasri H, Gharipour, et al. Contrast-induced nephropathy; a literature review. J Nephropathol. 2014 ; 3 ((2)). 51-56
22. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 ; 68 ((1)). 14-22
23. Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome). J Am Coll Cardiol. 2014 ; 63 ((1)). 71-79
24. Han Y, Zhu G, Han L, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014 ; 63 ((1)). 62-70
25. Mikhailidis DP, Athyros VG. Acute kidney injury: short-term statin therapy for prevention of contrast-induced AKI. Nat Rev Nephrol. 2014 ; 10 ((1)). 8-9
26. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002 ; 89 ((3)). 356-358
27. Erturk M, Uslu N, Gorgulu S, et al. Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?. Coron Artery Dis. 2014 ; 25 ((2)). 111-117
28. Gurm HS, Dixon SR, Smith DE, et al. BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011 ; 58 ((9)). 907-914
29. Laskey WK, Jenkins C, Selzer F, et al. NHLBI Dynamic Registry Investigators. Volume-to creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007 ; 50 ((7)). 584-590
30. Pyxaras S, Sinagra G, Mangiacapra F, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am J Cardiol. 2013 ; 111 ((5)). 684-688
31. Ishibashi Y, Yamauchi M, Musha H, Mikami T, Kawasaki K, Miyake F. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization. Angiology. 2010 ; 61 ((8)). 724-730